We are live on ! Find out more
IQMD

Intelligent Medicine Acquisition Corp. Class A Common Stock
IQMD

Delisted

IQMD was delisted on the 26th of April, 2023.

Back to rankings

58 hedge funds and large institutions have $161M invested in Intelligent Medicine Acquisition Corp. Class A Common Stock in 2022 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 18 increasing their positions, 4 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

350% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 4

5% more capital invested

Capital invested by funds: $154M → $161M (+$7.5M)

0% more funds holding

Funds holding: 58 → 58 (0)

0% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 7

Holders
58
Holders Change
–
Holders Change %
0%
% of All Funds
1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
18
Reduced
4
Closed
7
Calls
$101K
Puts
–
Net Calls
+$101K
Net Calls Change
+$1K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$4.2M
2
FTCM
First Trust Capital Management
Illinois
+$1.12M
3
MF
Magnetar Financial
Illinois
+$1.05M
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$1.01M
5
AA
AQR Arbitrage
Connecticut
+$987K

Top Sellers

Rank Fund Capital Flow
1
CF
Cantor Fitzgerald
New York
-$4.01M
2
JP Morgan Chase
JP Morgan Chase
New York
-$1M
3
ECU
Eisler Capital (UK)
United Kingdom
-$803K
4
KC
Kryger Capital
United Kingdom
-$421K
5
UOC
UBS O'Connor
Illinois
-$384K
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
1
Saba Capital Management
New York
$21.9M – – –
HCM
2
Highbridge Capital Management
New York
$9.68M +$47.7K +4,750 +0.5%
SC
3
Sculptor Capital
New York
$8.7M +$62K +6,169 +0.7%
PC
4
Periscope Capital
Ontario, Canada
$8.1M – – –
D.E. Shaw & Co
5
D.E. Shaw & Co
New York
$7.91M +$6.15K +612 +0.1%
Millennium Management
6
Millennium Management
New York
$6.87M +$4.2M +418,471 +158%
HSBC Holdings
7
HSBC Holdings
United Kingdom
$6.6M – – –
Marshall Wace
8
Marshall Wace
United Kingdom
$6.25M +$933K +92,955 +18%
AA
9
AQR Arbitrage
Connecticut
$5.57M +$987K +98,282 +22%
PAMP
10
Polar Asset Management Partners
Ontario, Canada
$5.44M +$406K +40,400 +8%
MI
11
MMCAP International
Cayman Islands
$5.04M – – –
AC
12
Aristeia Capital
Connecticut
$4.6M +$384K +38,221 +9%
CSS
13
Cubist Systematic Strategies
Connecticut
$4.57M +$147K +14,629 +3%
FTCM
14
First Trust Capital Management
Illinois
$4.34M +$1.12M +111,300 +35%
SCM
15
Shaolin Capital Management
Florida
$4.23M +$201K +20,000 +5%
WRBC
16
W.R. Berkley Corp
Connecticut
$4.09M – – –
UOC
17
UBS O'Connor
Illinois
$3.85M -$384K -38,221 -9%
MF
18
Magnetar Financial
Illinois
$3.44M +$1.05M +104,346 +44%
RCM
19
Radcliffe Capital Management
Pennsylvania
$3.03M +$8.94K +890 +0.3%
Balyasny Asset Management
20
Balyasny Asset Management
Illinois
$3.02M +$1.01M +100,161 +50%
FTCM
21
Fir Tree Capital Management
New York
$2.98M – – –
KL
22
KIM LLC
Kansas
$2.52M – – –
TCM
23
Tenor Capital Management
New York
$2.52M – – –
Hudson Bay Capital Management
24
Hudson Bay Capital Management
Connecticut
$2.52M -$803 -80 -0%
WAM
25
Weiss Asset Management
Massachusetts
$2.43M – – –
1
2 3

IQMD Hedge Fund Activity: Q3 2022 in Review

58 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) for Q3 2022, worth a combined $161M — up 4.9% from $154M a quarter earlier.

Fund positioning in IQMD was balanced in Q3 2022: 7 funds opened new positions, 7 closed out, 18 added to existing stakes and 4 trimmed.

The largest buyer was Millennium Management, adding an estimated $4.2M. The largest seller was Cantor Fitzgerald, exiting entirely with an estimated $4.01M sold.

  • 58 institutional investors held Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) as of Q3 2022, unchanged from Q2 2022.
  • Funds reported $161M of Intelligent Medicine Acquisition Corp. Class A Common Stock stock for Q3 2022, up 4.9% quarter-over-quarter.
  • 7 funds opened new Intelligent Medicine Acquisition Corp. Class A Common Stock positions in Q3 2022 and 7 closed out, a net change of 0 holders.
  • The largest Intelligent Medicine Acquisition Corp. Class A Common Stock buyer in Q3 2022 was Millennium Management, an estimated $4.2M added.
  • The largest Intelligent Medicine Acquisition Corp. Class A Common Stock seller in Q3 2022 was Cantor Fitzgerald, an estimated $4.01M sold.

Based on aggregated 13F filings for Q3 2022.